Last 12 months
Inside the activity.
0 purchase rows · 34 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 9 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 17, 2024 Filed Oct 18, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-043696 · form4.xml · nonDerivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 17, 2024 Filed Oct 21, 2024 20:05 UTC |
Hagen HeidiDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001140361-24-043798 · form4.xml · derivative · entry 4 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017. F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. Read SEC document |
| October 17, 2024 Filed Oct 21, 2024 20:05 UTC |
Hagen HeidiDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 4,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001140361-24-043798 · form4.xml · derivative · entry 3 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 4,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015. F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. Read SEC document |
| October 17, 2024 Filed Oct 21, 2024 20:05 UTC |
Hagen HeidiDirector
|
Exercise / conversionCommon Stock | 6,000 | $3.74 | $22,440.00 |
DisclosureSEC source: 0001140361-24-043798 · form4.xml · nonDerivative · entry 2 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. Read SEC document |
| October 17, 2024 Filed Oct 21, 2024 20:05 UTC |
Hagen HeidiDirector
|
Exercise / conversionCommon Stock | 4,000 | $3.74 | $14,960.00 |
DisclosureSEC source: 0001140361-24-043798 · form4.xml · nonDerivative · entry 1 Hagen Heidi · CIK 0001585084 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The Reporting Person has elected to exercise and hold these shares at this time. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-043696 · form4.xml · derivative · entry 5 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,500 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $41.38 | $724,150.00 |
DisclosureSEC source: 0001140361-24-043696 · form4.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-043696 · form4.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:05 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,833 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001140361-24-043695 · form4.xml · derivative · entry 3 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,833 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:05 UTC |
GILMAN STEVEN CDirector
|
SaleCommon Stock | 5,833 | $41.36 | $241,252.88 |
DisclosureSEC source: 0001140361-24-043695 · form4.xml · nonDerivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,000 F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. Read SEC document |
| October 16, 2024 Filed Oct 18, 2024 20:05 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionCommon Stock | 5,833 | $13.05 | $76,120.65 |
DisclosureSEC source: 0001140361-24-043695 · form4.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 20:06 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,833 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001140361-24-042882 · form4.xml · derivative · entry 3 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,833 Underlying: Common Stock · 5,833 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company. Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 20:06 UTC |
GILMAN STEVEN CDirector
|
SaleCommon Stock | 5,833 | $40.35 | $235,361.55 |
DisclosureSEC source: 0001140361-24-042882 · form4.xml · nonDerivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,000 F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. Read SEC document |
| October 02, 2024 Filed Oct 4, 2024 20:06 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionCommon Stock | 5,833 | $13.05 | $76,120.65 |
DisclosureSEC source: 0001140361-24-042882 · form4.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,833 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:06 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
SaleCommon Stock | 568 | $41.90 | $23,799.20 |
DisclosureSEC source: 0001140361-24-042559 · form4.xml · nonDerivative · entry 3 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,124 F4 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 13, 2024. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:06 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 937 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-042559 · form4.xml · derivative · entry 4 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 938 Underlying: Common Stock · 937 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation. F7 · price: The Fair Market Value of the vested derivative securities is $42.25 per share. F1 · derivative.exercise_date: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest on September 30, 2025. F6 · derivative.expiration_date: No expiration date for this type of award. Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:06 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 369 | $42.25 | $15,590.25 |
DisclosureSEC source: 0001140361-24-042559 · form4.xml · nonDerivative · entry 2 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,692 F3 · shares: These shares were withheld by the Issuer to satisfy the tax withholding requirements in connection with the vesting of RSUs. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 20:06 UTC |
SIEGAL JONATHANPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 937 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-24-042559 · form4.xml · nonDerivative · entry 1 SIEGAL JONATHAN · CIK 0001916145 · Principal Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,061 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on September 30, 2021. The remaining RSUs will vest on September 30, 2025. F2 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 30, 2024 Filed Feb 13, 2025 21:05 UTC |
Halpin MichaelChief Operating Officer
|
GrantCommon Stock | 120 | $35.91 | $4,309.20 |
DisclosureSEC source: 0001140361-25-004301 · form5.xml · nonDerivative · entry 2 Halpin Michael · CIK 0001778858 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,499 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 30, 2024 Filed Feb 13, 2025 21:05 UTC |
Flynn Sean C.Chief Legal Officer
|
GrantCommon Stock | 49 | $35.91 | $1,759.59 |
DisclosureSEC source: 0001140361-25-004300 · form5.xml · nonDerivative · entry 1 Flynn Sean C. · CIK 0001801993 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 756 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 30, 2024 Filed Feb 13, 2025 21:05 UTC |
Mara Joseph Anthony JrChief Financial Officer
|
GrantCommon Stock | 76 | $35.91 | $2,729.16 |
DisclosureSEC source: 0001140361-25-004299 · form5.xml · nonDerivative · entry 1 Mara Joseph Anthony Jr · CIK 0001841148 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,511 F1 · shares: Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 20:05 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,834 | $0.00 Strike: $13.05 | $0.00 |
DisclosureSEC source: 0001140361-24-041562 · form4.xml · derivative · entry 3 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,666 Underlying: Common Stock · 5,834 shares Expires 2028-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 17,500 shares, became exercisable in equal monthly installments over a period of one year, beginning on May 2, 2018, contingent upon continued service to the Company. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 20:05 UTC |
GILMAN STEVEN CDirector
|
SaleCommon Stock | 5,834 | $45.54 | $265,680.36 |
DisclosureSEC source: 0001140361-24-041562 · form4.xml · nonDerivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,000 F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 20:05 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionCommon Stock | 5,834 | $13.05 | $76,133.70 |
DisclosureSEC source: 0001140361-24-041562 · form4.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-041053 · form4.xml · derivative · entry 6 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $43.90 | $768,250.00 |
DisclosureSEC source: 0001140361-24-041053 · form4.xml · nonDerivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 12, 2024 Filed Sep 13, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-041053 · form4.xml · nonDerivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-041053 · form4.xml · derivative · entry 5 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $43.37 | $758,975.00 |
DisclosureSEC source: 0001140361-24-041053 · form4.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 11, 2024 Filed Sep 13, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-041053 · form4.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 20:06 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001140361-24-040228 · form4.xml · derivative · entry 3 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options, representing the right to purchase 5,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015. F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 20:06 UTC |
GILMAN STEVEN CDirector
|
SaleCommon Stock | 5,000 | $48.58 | $242,900.00 |
DisclosureSEC source: 0001140361-24-040228 · form4.xml · nonDerivative · entry 2 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,000 F1 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 30, 2024. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 20:06 UTC |
GILMAN STEVEN CDirector
|
Exercise / conversionCommon Stock | 5,000 | $3.74 | $18,700.00 |
DisclosureSEC source: 0001140361-24-040228 · form4.xml · nonDerivative · entry 1 GILMAN STEVEN C · CIK 0001379970 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $10.95 | $0.00 |
DisclosureSEC source: 0001140361-24-040225 · form4.xml · derivative · entry 3 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 12,604 Underlying: Common Stock · 10,000 shares Expires 2028-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 135,000 shares, became exercisable on August 20, 2019, the first anniversary of the date of grant, with 25% vesting and the remaining 75% vesting in equal quarterly installments over three years thereafter, contingent upon continued service to the Company. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
SaleCommon Stock | 10,000 | $49.83 | $498,300.00 |
DisclosureSEC source: 0001140361-24-040225 · form4.xml · nonDerivative · entry 2 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,229 F2 · shares: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 28, 2024. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 20:05 UTC |
Hopper Jonathan MarkChief Medical Officer
|
Exercise / conversionCommon Stock | 10,000 | $10.95 | $109,500.00 |
DisclosureSEC source: 0001140361-24-040225 · form4.xml · nonDerivative · entry 1 Hopper Jonathan Mark · CIK 0001626325 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-037672 · form4.xml · derivative · entry 6 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $46.24 | $809,200.00 |
DisclosureSEC source: 0001140361-24-037672 · form4.xml · nonDerivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 15, 2024 Filed Aug 16, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-037672 · form4.xml · nonDerivative · entry 3 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-037672 · form4.xml · derivative · entry 5 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 122,500 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $45.17 | $790,475.00 |
DisclosureSEC source: 0001140361-24-037672 · form4.xml · nonDerivative · entry 2 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 14, 2024 Filed Aug 16, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionCommon Stock | 17,500 | $3.02 | $52,850.00 |
DisclosureSEC source: 0001140361-24-037672 · form4.xml · nonDerivative · entry 1 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 238,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
GrantStock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001140361-24-036617 · form4.xml · derivative · entry 6 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,000 Underlying: Common Stock · 2,000 shares Expires not disclosed F4 · derivative.exercise_date: These options, representing the right to purchase 15,000 shares, were originally granted on March 20, 2015, with 624 shares becoming exercisable on the grant date, 312 shares becoming exercisable on March 31, 2015, and the remainder becoming exercisable in equal monthly installments, contingent upon continued service to the Company, from April 30, 2015 through December 31, 2017. F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $3.74 | $0.00 |
DisclosureSEC source: 0001140361-24-036617 · form4.xml · derivative · entry 5 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires not disclosed F2 · derivative.exercise_date: These options, representing the right to purchase 5,000 shares, became exercisable in three installments, contingent upon continued service to the Company, with the first vesting date on March 20, 2015, which was the date on which the option was granted, and the final vesting date on May 1, 2015. F3 · derivative.expiration_date: These options, which were awarded on March 20, 2015, would otherwise expire and become forfeitable on March 20, 2025. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
SaleCommon Stock | 2,000 | $45.99 | $91,980.00 |
DisclosureSEC source: 0001140361-24-036617 · form4.xml · nonDerivative · entry 4 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,900 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionCommon Stock | 2,000 | $3.74 | $7,480.00 |
DisclosureSEC source: 0001140361-24-036617 · form4.xml · nonDerivative · entry 3 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
SaleCommon Stock | 5,000 | $45.92 | $229,600.00 |
DisclosureSEC source: 0001140361-24-036617 · form4.xml · nonDerivative · entry 2 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,900 F1 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2024. Read SEC document |
| August 07, 2024 Filed Aug 9, 2024 20:05 UTC |
MCLAUGHLIN KEVIN FDirector
|
Exercise / conversionCommon Stock | 5,000 | $3.74 | $18,700.00 |
DisclosureSEC source: 0001140361-24-036617 · form4.xml · nonDerivative · entry 1 MCLAUGHLIN KEVIN F · CIK 0001214938 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 17,500 | $0.00 Strike: $3.02 | $0.00 |
DisclosureSEC source: 0001140361-24-033595 · form4.xml · derivative · entry 6 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 17,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options, representing the right to purchase 440,000 shares, became exercisable in equal quarterly installments, contingent upon continued service to the Company, with the first vesting date on April 5, 2015, which was one quarter after the date on which the option was granted. F4 · derivative.expiration_date: These options, which were awarded on January 5, 2015, would otherwise expire and become forfeitable on January 5, 2025. Read SEC document |
| July 18, 2024 Filed Jul 19, 2024 20:05 UTC |
Colangelo DominickDirector · President and CEO
|
SaleCommon Stock | 17,500 | $51.40 | $899,500.00 |
DisclosureSEC source: 0001140361-24-033595 · form4.xml · nonDerivative · entry 4 Colangelo Dominick · CIK 0001313403 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 220,937 F2 · acquired: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 1, 2023. F1 · balance_after: These shares include shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.